Michel Vounatsos
Fortuna: 3 M $ al 31/05/2026
Fortuna: 3 M $ al 31/05/2026
Michel Vounatsos es miembro del consejo de administración de PerkinElmer, Inc. (Estados Unidos), LInstitut de RYthmologie et Modlisation Cardiaque y n-Lorem Foundation, y director general y consejero de Biogen, Inc. En su anterior carrera ocupó el cargo de Presidente de la Línea de Negocio de Atención Primaria y Clientes en Merck & Co. El Sr. Vounatsos obtuvo un MBA en la Escuela de Altos Estudios Comerciales de París.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REVVITY, INC. 0,01 % | 07/05/2026 | 13.977 ( 0,01 % ) | 1 M $ | 31/05/2026 |
ZAI LAB LTD. 0,06 % | 17/06/2026 | 727.870 ( 0,06 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REVVITY, INC. | Director/Miembro de la Junta | 01/03/2020 |
| ZAI LAB LIMITED | Director/Miembro de la Junta | 07/01/2023 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director Ejecutivo | 06/01/2017 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Director Ejecutivo | - |
L’Institut de RYthmologie et Modélisation Cardiaque | Presidente | - |
n-Lorem Foundation
n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Director/Miembro de la Junta | - |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Director Ejecutivo | 14/11/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment | Health Technology |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Health Technology |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
L’Institut de RYthmologie et Modélisation Cardiaque | |
n-Lorem Foundation
n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.